ReviewPharmaceutics2021

Kinase Inhibition in Relapsed/Refractory Leukemia and Lymphoma Settings: Recent Prospects into Clinical Investigations.

Caio Bezerra Machado et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.